Nuveen
NRC icon

Nuveen’s NRC Health Common Stock NRC Stock Holding History

Nuveen’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$654K Buy
30,318
+2,754
+10% +$51.1K ﹤0.01% 3147
2026
Q1 		$468K Buy
27,564
+227
+0.8% +$3.86K ﹤0.01% 2864
2025
Q4 		$513K Sell
27,337
-6,300
-19% -$95.1K ﹤0.01% 2859
2025
Q3 		$430K Hold
33,637
– – ﹤0.01% 2950
2025
Q2 		$565K Sell
33,637
-5,598
-14% -$75.6K ﹤0.01% 2844
2025
Q1 		$502K Hold
39,235
– – ﹤0.01% 2903
2024
Q4 		$692K Hold
39,235
– – ﹤0.01% 2864
2024
Q3 		$897K Hold
39,235
– – ﹤0.01% 2808
2024
Q2 		$900K Hold
39,235
– – ﹤0.01% 2771
2024
Q1 		$1.55M Hold
39,235
– – ﹤0.01% 2508
2023
Q4 		$1.55M Buy
39,235
+1,053
+3% +$44.1K ﹤0.01% 2525
2023
Q3 		$1.69M Sell
38,182
-19,035
-33% -$831K ﹤0.01% 2370
2023
Q2 		$2.49M Buy
57,217
+616
+1% +$27.1K ﹤0.01% 2252
2023
Q1 		$2.46M Buy
56,601
+114
+0.2% +$5.03K ﹤0.01% 2254
2022
Q4 		$2.11M Sell
56,487
-1,363
-2% -$52.7K ﹤0.01% 2368
2022
Q3 		$2.3M Sell
57,850
-904
-2% -$33.5K ﹤0.01% 2331
2022
Q2 		$2.25M Buy
58,754
+520
+0.9% +$18.8K ﹤0.01% 2378
2022
Q1 		$2.29M Buy
58,234
+1,728
+3% +$67.6K ﹤0.01% 2437
2021
Q4 		$2.35M Sell
56,506
-3,405
-6% -$148K ﹤0.01% 2495
2021
Q3 		$2.53M Sell
59,911
-13,231
-18% -$666K ﹤0.01% 2565
2021
Q2 		$3.36M Buy
73,142
+10,944
+18% +$521K ﹤0.01% 2457
2021
Q1 		$2.91M Sell
62,198
-189
-0.3% -$9.19K ﹤0.01% 2435
2020
Q4 		$2.67M Buy
62,387
+2,633
+4% +$135K ﹤0.01% 2361
2020
Q3 		$2.94M Sell
59,754
-2,262
-4% -$125K ﹤0.01% 2195
2020
Q2 		$3.61M Buy
62,016
+11,012
+22% +$582K ﹤0.01% 2072
2020
Q1 		$2.32M Buy
51,004
+248
+0.5% +$14.9K ﹤0.01% 2119
2019
Q4 		$3.35M Sell
50,756
-1,119
-2% -$68.4K ﹤0.01% 2196
2019
Q3 		$3M Buy
51,875
+1,165
+2% +$72.2K ﹤0.01% 2212
2019
Q2 		$2.92M Buy
+50,710
New +$2.35M ﹤0.01% 2252

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nuveen's NRC Position: Q2 2026 in Review

Nuveen increased its NRC Health Common Stock (NRC) stake by 10% in Q2 2026, buying an estimated $51.1K and bringing the position to 30,318 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

Nuveen first reported a position in NRC in Q2 2019 and has held it in 29 quarters since. The position peaked at $3.61M in Q2 2020. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Nuveen held 30,318 shares of NRC Health Common Stock worth $654K as of Q2 2026.
  • Nuveen bought 2,754 NRC Health Common Stock shares in Q2 2026, an estimated $51.1K.
  • NRC Health Common Stock made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3147 holding.
  • Nuveen first reported a position in NRC Health Common Stock in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's NRC Health Common Stock position peaked at $3.61M in Q2 2020.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.